Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05064280
What this trial is testing

Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases

Who this might be right for
Brain MetastasesTumor
M.D. Anderson Cancer Center 104
Not applicableLooking for participantsNCT00196742
What this trial is testing

Fabry Disease Registry & Pregnancy Sub-registry

Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company 9,000
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableUnknownNCT03717454
What this trial is testing

Dopamine D2 Receptors(D2R) Imaging in Prolactinomas

Who this might be right for
Prolactinoma
Zhebao Wu 50
Early research (Phase 1)UnknownNCT00003842
What this trial is testing

IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma

Who this might be right for
Brain and Central Nervous System Tumors
Barrett Cancer Center 30
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Not applicableLooking for participantsNCT07594262
What this trial is testing

NET-TIME: Inflammatory Tumor Microenvironment in Pituitary Neoplasm

Who this might be right for
Pituitary Tumor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 60
Not applicableUnknownNCT06042946
What this trial is testing

Microsurgical Resection of Intramedullary Spinal Cord Metastases

Who this might be right for
Spinal Cord MetastasisSpinal Cord Tumor Malignant IntramedullaryFunctional Outcome+2 more
Cantonal Hospital of St. Gallen 60
Not applicableStudy completedNCT07716579
What this trial is testing

Assessment of Endocrine and Metabolic Late Effects After Childhood Brain Tumor Treatment

Who this might be right for
Brain NeoplasmsEndocrine System DiseasesMetabolic Diseases
Institute of Oncology Ljubljana 12
Not applicableStudy completedNCT02732769
What this trial is testing

Clinical Evaluation of the Treatment of Intellectual Metastases by Radiosurgery Gamma Knife by Means of a Support System by Mask.

Who this might be right for
Lung CancerBrain Metastases
Assistance Publique Hopitaux De Marseille 58
Early research (Phase 1)Study completedNCT00390403
What this trial is testing

Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Not applicableActive Not RecruitingNCT07389642
What this trial is testing

Brain Oligometastasis in NSCLC

Who this might be right for
Brain OligometastaticNon-small Cell Lung Cancer
University Hospital, Bordeaux 46
Testing effectiveness (Phase 2)Study completedNCT01448096
What this trial is testing

Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma

Who this might be right for
Large B Cell Diffuse Lymphoma
Chonbuk National University Hospital 33
Early research (Phase 1)Ended earlyNCT03558750
What this trial is testing

Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma

Who this might be right for
Recurrent Central Nervous System LymphomaRecurrent Diffuse Large B-Cell LymphomaRefractory Central Nervous System Lymphoma+1 more
Vanderbilt-Ingram Cancer Center 6
Not applicableEnded earlyNCT02039778
What this trial is testing

Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma

Who this might be right for
GlioblastomaMalignant GliomaBrain Tumors+1 more
Beth Israel Medical Center 4
Not applicableEnded earlyNCT02565433
What this trial is testing

Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-1302)

Who this might be right for
Neoplasm Metastases
Centre Oscar Lambret 52
Testing effectiveness (Phase 2)UnknownNCT04675008
What this trial is testing

Central Nervous System(CNS) Efficacy of Dacomitinib

Who this might be right for
Non Small Cell Lung CancerBrain Metastases
Samsung Medical Center 30
Testing effectiveness (Phase 2)UnknownNCT04061408
What this trial is testing

FSRT in Breast Cancer Patients With Brain Metastases

Who this might be right for
Breast CancerBrain Metastases
Fudan University 170
Testing effectiveness (Phase 2)Looking for participantsNCT04923126
What this trial is testing

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

Who this might be right for
Low-Grade GliomaRecurrent Low-Grade GliomaProgressive Low-Grade Glioma
St. Jude Children's Research Hospital 132
Very early researchStudy completedNCT01770626
What this trial is testing

A Pilot Study to Determine Nutrition Status in Glioblastoma Multiforme Patients

Who this might be right for
Brain Cancer
University of Alabama at Birmingham 40
Next Page